US Repackager Spectrum gets USFDA 483 wi
Spectrum Laboratories Inc, New Jersey, USA (FEI 2246824) was inspected by FDA investigators Sayyem H
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Spectrum Laboratories Inc, New Jersey, USA (FEI 2246824) was inspected by FDA investigators Sayyem H
Centaur India formulation facility at Pune, Maharashtra, India was issued Warning letter by FDA citing
The USFDA Warning letter to K. C. Pharmaceuticals issued in August 2023, following inspection at